SHAWNEE, Kan., Aug. 2, 2011 /PRNewswire/ -- Bayer HealthCare LLC, Animal Health Division will license and distribute SentrX Animal Care’s equitrX® Wound Healing Spray Gel and equitrX® Corneal Repair Gel Drops for horses. These two SentrX products will be available to licensed veterinarians through Bayer Animal Health on July 18, 2011. This agreement allows Bayer Animal Health to offer equine veterinarians wound management products, a new addition to the existing Bayer portfolio.
“The equitrX products are prescription products sold only to licensed veterinarians. It is crucial to have an equine veterinarian involved in the management of some of these equine wounds and corneal ulcers,” said Scott King, DVM, Equine Products Manager for Bayer.
“These products are based on patented technology that cross-links modified hyaluronic acid molecules, a process that results in enhanced wound healing,” said Richard Koehn, Ph.D., President & CEO, SentrX Animal Care, Inc. “We are excited to be working with Bayer whose mission is Science for a Better Life on this project and look forward to potential future project collaboration as well.”
“Horse owners want wounds to heal as nicely as possible. We liked these products because they provide a molecular matrix to enhance wound healing by facilitating cellular migration,” said Dr. King.
For more information on Bayer HealthCare Animal Health Division and equine treatments from Bayer visit www.bayerequineconnection.com.
Caution: Federal (USA) Law restricts these products to use by or on the order of a licensed veterinarian. For use only in horses. Not for use in horses intended for human consumption.
SentrX Animal Care is a research and development company based in Salt Lake City, Utah.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide.
With sales of EUR 1,120 million (2010), Bayer’s Animal Health division is one of the world’s leading manufacturers of veterinary drugs. The business manufactures and markets approximately 100 different veterinary drugs and care products for food-supplying animals and companion animals. U.S. Headquarters for Bayer HealthCare LLC, Animal Health Division is located in Shawnee, Kansas. Find more information at www.bayerhealthcare.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.
©Bayer and the Bayer Cross are registered trademarks of Bayer.
equitrX is a registered trademark of SentrX Animal Care.
SOURCE Bayer HealthCare LLC, Animal Health Division
